These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Abnormal values of the immunological parameters in dystrophia myotonica. The results of complex research on the members of 3 generations of a family]. Opavský J; Podivínský J; Trnecka J; Matousková I; Válková Z Acta Univ Palacki Olomuc Fac Med; 1982; 102():311-21. PubMed ID: 6242585 [No Abstract] [Full Text] [Related]
29. Involuntary muscle involvement in dystrophia myotonica. Case report. Maze M; Novis BH; Lurie BB; Bank S S Afr Med J; 1973 Oct; 47(41):1947-50. PubMed ID: 4748660 [No Abstract] [Full Text] [Related]
30. Marfan's syndrome and dystrophia myotonica. Dyken P N Engl J Med; 1966 Apr; 274(16):915; author reply 915-6. PubMed ID: 17929362 [No Abstract] [Full Text] [Related]
31. The use of genetic linkage in counselling families with dystrophia myotonica. Gibson SL; Ferguson-Smith MA Clin Genet; 1980 Jun; 17(6):443-8. PubMed ID: 7398118 [TBL] [Abstract][Full Text] [Related]
33. [Fatal arrhythmia following administration of suxamethonium to a postpartum woman who subsequently was found to have dystrophia myotonica]. Wildschut HI; Verhoef S; Schilder JL; Hamel BC Ned Tijdschr Geneeskd; 1996 Sep; 140(38):1923-4. PubMed ID: 8927172 [No Abstract] [Full Text] [Related]
34. The early detection of dystrophia myotonica. Polgar JG; Bradley WG; Upton AR; Anderson J; Howat JM; Petito F; Roberts DF; Scopa J Brain; 1972; 95(4):761-6. PubMed ID: 4567107 [No Abstract] [Full Text] [Related]
35. Cataract and myotonic dystrophy: the role of molecular diagnosis. Reardon W; MacMillan JC; Myring J; Harley HG; Rundle SA; Beck L; Harper PS; Shaw DJ Br J Ophthalmol; 1993 Sep; 77(9):579-83. PubMed ID: 8218057 [TBL] [Abstract][Full Text] [Related]
36. Transitional forms between myotonia congenita, dystrophia myotonica and paramyotonia congenita. Caughey JE N Z Med J; 1968 Mar; 67(429):347-50. PubMed ID: 5239622 [No Abstract] [Full Text] [Related]
37. [Central genesis of dystrophia myotonica and Tegretal therapy]. Jusić A; Stimac D Fortschr Neurol Psychiatr Grenzgeb; 1972 Feb; 40(2):105-12. PubMed ID: 4481995 [No Abstract] [Full Text] [Related]
38. Abnormalities of insulin secretion in dystrophia myotonica. Walsh JC; Turtle JR; Miller S; McLeod JG Brain; 1970; 93(4):731-42. PubMed ID: 5490274 [No Abstract] [Full Text] [Related]
39. [Blood group antigens and ABH secretor status in dystrophia myotonica (Curschmann-Steinert)]. Mielke U; Gramer L; Schimrigk K Klin Padiatr; 1986; 198(4):312-5. PubMed ID: 3762003 [TBL] [Abstract][Full Text] [Related]
40. [Perioperative treatment of a patient with myotonic muscular dystrophy (Curschmann-Steinert disease)]. Thölke MH; Tolksdorf W; Mitrenga I Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Apr; 26(2):87-9. PubMed ID: 1873417 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]